An inhibitor of glycolysis is shown to have antiepileptic effects in the rat kindling model, possibly through NADH-dependent regulation of gene expression. This may explain how the 'ketogenic diet' treatment works.
References
Engel, J. & Pedley, T. in Epilepsy: A Comprehensive Textbook 1339–1342 (Lippincott-Raven, Philadelphia, 1997).
Garriga-Canut, M. et al. Nat. Neurosci. 9, 1382–1387 (2006).
He, X. et al. Neuron 43, 31–42 (2004).
Chong, J.A. et al. Cell 80, 949–957 (1995).
Schoenherr, C.J. & Anderson, D.J. Science 267, 1360–1363 (1995).
Magistretti, P.J. J. Exp. Biol. 209, 2304–2311 (2006).
Li, Z. et al. Cell 119, 873–887 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Huang, Y., McNamara, J. Inhibiting glycolysis to reduce seizures: how it might work. Nat Neurosci 9, 1351–1352 (2006). https://doi.org/10.1038/nn1106-1351
Issue Date:
DOI: https://doi.org/10.1038/nn1106-1351
- Springer Nature America, Inc.
This article is cited by
-
NRSF: an Angel or a Devil in Neurogenesis and Neurological Diseases
Journal of Molecular Neuroscience (2015)